Evocalcet Rescues Secondary Hyperparathyroidism-driven Cortical Porosity in CKD Male Rats

To elucidate the effect of evocalcet, a new oral calcimimetic to bone of secondary hyperparathyroidism (SHPT) with chronic kidney disease (CKD), the rats were 5/6 nephrectomized and fed on a high-phosphate diet. The treated rats were then divided into vehicle groups and evocalcet administered groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Tomoka, Tokunaga, Shin, Yamamoto, Tomomaya, Sakai, Mariko, Hongo, Hiromi, Kawata, Takehisa, Amizuka, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939342/
https://www.ncbi.nlm.nih.gov/pubmed/36718587
http://dx.doi.org/10.1210/endocr/bqad022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939342/
https://www.ncbi.nlm.nih.gov/pubmed/36718587
http://dx.doi.org/10.1210/endocr/bqad022

Ejemplares similares